Subscribe to our channel! rupt.ly/subscribe Russian biotech company BIOCAD has registered a locally developed drug to treat complications in COVID-19 patients, confirmed the general director of the company, Dmitry Morozov, during an interview on Monday. Use of interleukin-6 glycoprotein inhibitor…